AS we cross the threshold of 60 years old, our bodies undergo significant physiological shifts that directly impact nutritional requirements. Metabolism slows, muscle mass declines (a condition known ...
A new 'living guideline' from the American College of Physicians (ACP) recommends semaglutide (Wegovy) and tirzepatide ...
YOU ARE HERE: Home > Guidelines and Clinical Policy > ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators ...
In these 2025 Advanced Life Support Guidelines, the American Heart Association provides comprehensive recommendations for the resuscitation and management of adults experiencing cardiac arrest, ...
Cardiovascular-Kidney-Metabolic Syndrome Staging: Cardiovascular-kidney-metabolic (CKM) syndrome staging is recommended for youths and adults to prevent CKM stage progression, to tailor therapy to ...
The new 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome is the first ever to address the "interrelated ...
The American Diabetes Association (ADA) recently released their 2025 Standards of Care, which – for the first time – includes recommendations for CGM use in type 2 diabetes, the use of GLP-1 drugs for ...
The therapeutic landscape of hematological malignancies has been transformed by targeted therapies, immunotherapy, and cellular therapies, leading to more complex and prolonged clinical courses.
Allogeneic haematopoietic cell transplantation (HCT) is a potentially curative treatment for both malignant and non-malignant hematologic disease, as well as some immunologic and metabolic disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results